Pelargonidin ameliorates reserpine-induced neuronal mitochondrial dysfunction and apoptotic cascade: a comparative in vivo study

References

• Alam, M., and Schmidt, W.J., 2004. L-DOPA reverses the hypokinetic behaviour and rigidity in rotenone-treated rats. Behavioural Brain Research, 153 (2), 439–446.
   PubMed Web of Science ®Google Scholar
• Al-Bloushi, S., et al., 2009. Green tea modulates reserpine toxicity in animal models. The Journal of Toxicological Sciences, 34 (1), 77–87..
   PubMed Web of Science ®Google Scholar
• Bai, P., 2015. Biology of Poly(ADP-Ribose) polymerases: the factotums of cell maintenance. Molecular Cell, 58 (6), 947–958.
   PubMed Web of Science ®Google Scholar
• Bancroft, J. D., Stevens, A., and Turner, D. R., 1996. Theory and practice of histological technique, fourth ed., Edinburgh, New York: Churchill Livingston. 273–292.
   Google Scholar
• Beutler, E., Duron, O., and KellY, B.M., 1963. Improved method for the determination of blood glutathione. The Journal of Laboratory and Clinical Medicine, 61, 882–888.
   PubMed Web of Science ®Google Scholar
• Brunyanszki, A., et al., 2016. Mitochondrial poly(ADP-ribose) polymerase: the wizard of Oz at work. Free Radical Biology and Medicine, 100, 257–270.
   PubMed Web of Science ®Google Scholar
• Curtin, N.J., and Szabo, C., 2013. Therapeutic applications of PARP inhibitors: anticancer therapy and beyond. Molecular Aspects of Medicine, 34 (6), 1217–1256.
   PubMed Web of Science ®Google Scholar
• Del Zoppo, G., et al., 2000. Inflammation and stroke: putative role for cytokines, adhesion molecules and iNOS in brain response to ischemia. Brain Pathology, 10 (1), 95–112. ‏
   PubMed Web of Science ®Google Scholar
• Demuro, S., et al., 2021. GSK-3β, FYN, and DYRK1A: master regulators in neurodegenerative pathways. International Journal of Molecular Sciences, 22 (16), 9098.
   PubMed Web of Science ®Google Scholar
• Doyle, A.E., McQueen, E.G., and Smirk, F.H., 1955. Treatment of hypertension with reserpine, with reserpine in combination with pentapyrrolidinium, and with reserpine in combination with veratrum alkaloids. Circulation, 11 (2), 170–181.
   PubMed Web of Science ®Google Scholar
• El-Ghazaly, M.A., et al., 2015. Neuroprotective effect of EGb761® and low-dose whole-body γ-irradiation in a rat model of Parkinson's disease. Toxicology and Industrial Health, 31 (12), 1128–1143.
   PubMed Web of Science ®Google Scholar
• Ghavami, S., et al., 2014. Autophagy and apoptosis dysfunction in neurodegenerative disorders. Progress in Neurobiology, 112, 24–49.
   PubMed Web of Science ®Google Scholar
• Halmosi, R., et al., 2001. Effect of poly(ADP-ribose) polymerase inhibitors on the ischemia-reperfusion-induced oxidative cell damage and mitochondrial metabolism in Langendorff heart perfusion system. Molecular Pharmacology, 59 (6), 1497–1505.
   PubMed Web of Science ®Google Scholar
• Hamalainen, M., et al., 2007. Anti-inflammatory effects of flavonoids: genistein, kaempferol, quercetin, and daidzein inhibit STAT-1 and NFkappaB activations, whereas flavone, isorhamnetin, naringenin, and pelargonidin inhibit only NF-kappa B activation along with their inhibitory effect on iNOS expression and NO production in activated macrophages. Mediators of Inflammation, 2007, 45673.
   PubMed Web of Science ®Google Scholar
• Jeong, S., Ku, S.K., and Bae, J.S., 2017. Anti-inflammatory effects of pelargonidin on TGFBIp-induced responses. Canadian Journal of Physiology and Pharmacology, 95 (4), 372–381. ‏
   PubMed Web of Science ®Google Scholar
• Jiang, T., Sun, Q., and Chen, S., 2016. Oxidative stress: a major pathogenesis and potential therapeutic target of antioxidative agents in Parkinson's disease and Alzheimer's disease. Progress in Neurobiology, 147, 1–19.
   PubMed Web of Science ®Google Scholar
• Kaur, S., and Starr, M.S., 1997. Differential effects of intrastriatal and intranigral injections of glutamate antagonists on motor behaviour in the reserpine-treated rat. Neuroscience, 76 (2), 345–354. ‏
   PubMed Web of Science ®Google Scholar
• Krainz, T., et al., 2018. Synthesis and evaluation of a mitochondria-targeting Poly(ADP-ribose) Polymerase-1 Inhibitor. ACS Chemical Biology, 13 (10), 2868–2879. ‏
   PubMed Web of Science ®Google Scholar
• Laferriere, C.A., and Pang, D.S., 2020. Review of intraperitoneal injection of sodium pentobarbital as a method of euthanasia in laboratory rodents. Journal of the American Association for Laboratory Animal Science, 59 (3), 254–263.
   PubMed Web of Science ®Google Scholar
• Lee, I.C., and Bae, J.S., 2019. Pelargonidin protects against renal injury in a mouse model of sepsis. Journal of Medicinal Food, 22 (1), 57–61.
   PubMed Web of Science ®Google Scholar
• Liu, W.G., et al., 2004. Neuroprotection by pergolide against levodopa-induced cytotoxicity of neural stem cells. Neurochemical Research, 29 (12), 2207–2214.
   PubMed Web of Science ®Google Scholar
• Martire, S., Mosca, L., and d’Erme, M., 2015. PARP-1 involvement in neurodegeneration: a focus on Alzheimer’s and Parkinson’s diseases. Mechanisms of Ageing and Development, 146–148, 53–64.
   PubMed Web of Science ®Google Scholar
• Metzger, R.R., et al., 2002. Inhibitory effect of reserpine on dopamine transporter function. European Journal of Pharmacology, 456 (1–3), 39–43.
   PubMed Web of Science ®Google Scholar
• Miguel, M.G., 2011. Anthocyanins: antioxidant and/or anti-inflammatory activities. Journal of Applied Pharmaceutical Science, 1 (6), 7–15.
   Google Scholar
• Min, Y.S., et al., 2018. Endothelium independent effect of pelargonidin on vasoconstriction in rat aorta. Biomolecules & Therapeutics, 26 (4), 374–379.‏
   PubMed Web of Science ®Google Scholar
• Mingone, C.J., et al., 2003. Influence of heme and heme oxygenase-1 transfection of pulmonary microvascular endothelium on oxidant generation and cGMP. Experimental Biology and Medicine, 228 (5), 535–539.‏
   PubMed Web of Science ®Google Scholar
• Miranda, K.M., Espey, M.G., and Wink, D.A., 2001. A rapid, simple spectrophotometric method for simultaneous detection of nitrate and nitrite. Nitric Oxide: Biology and Chemistry, 5 (1), 62–71.
   PubMed Web of Science ®Google Scholar
• Noda, Y., et al., 2002. Antioxidant activities of pomegranate fruit extract and its anthocyanidins: delphinidin, cyanidin, and pelargonidin. Journal of Agricultural and Food Chemistry, 50 (1), 166–171.‏
   PubMed Web of Science ®Google Scholar
• Pall, M.L., 2008. Post-radiation syndrome as a NO/ONOO-cycle, chronic fatigue syndrome-like disease. Medical Hypotheses, 71 (4), 537–541.
   PubMed Web of Science ®Google Scholar
• Park, M.S., et al., 2015. Pharmacogenomic analysis indicates potential of 1,5-isoquinolinediol as a universal anti-aging agent for different tissues. Oncotarget, 6 (19), 17251–17260.
   PubMedGoogle Scholar
• Rashed, E., et al., 2021. Pelargonidin as an attenuator of neuronal mitochondrial dysfunction: an in vivo study. Research Square.doi:10.21203/rs.3.rs-407161/v1
   Google Scholar
• Reddy, P.H., 2007. Mitochondrial dysfunction in aging and Alzheimer's disease: strategies to protect neurons. Antioxidants & Redox Signaling, 9 (10), 1647–1658.
   PubMed Web of Science ®Google Scholar
• Reddy, P.H., 2009. Role of mitochondria in neurodegenerative diseases: mitochondria as a therapeutic target in Alzheimer's disease. CNS Spectrums, 14 (8 Suppl 7), 8–18.
   PubMed Web of Science ®Google Scholar
• Rogers, J., et al., 2007. Neuroinflammation in Alzheimer’s disease and Parkinson’s disease: are microglia pathogenic in either disorder? International Review of Neurobiology, 82, 235–246.
   PubMed Web of Science ®Google Scholar
• Roghani, M., et al., 2010. Oral pelargonidin exerts dose-dependent neuroprotection in 6-hydroxydopamine rat model of hemi-parkinsonism. Brain Research Bulletin, 82 (5–6), 279–283.
   PubMed Web of Science ®Google Scholar
• Roy, M., Sen, S., and Chakraborti, A.S., 2008. Action of pelargonidin on hyperglycemia and oxidative damage in diabetic rats: implication for glycation-induced hemoglobin modification. Life Sciences, 82 (21–22), 1102–1110.
   PubMed Web of Science ®Google Scholar
• Ruan, Q., et al., 2018. Targeting NAD + degradation: The therapeutic potential of flavonoids for Alzheimer's disease and cognitive frailty. Pharmacological Research, 128, 345–358.‏
   PubMed Web of Science ®Google Scholar
• Samadder, A., et al., 2017. Nano-pelargonidin protects hyperglycemic-induced L6 cells against mitochondrial dysfunction. Planta Medica, 83 (5), 468–475.
   PubMed Web of Science ®Google Scholar
• Sánchez-Fidalgo, S., et al., 2007. PARP inhibition reduces acute colonic inflammation in rats. European Journal of Pharmacology, 563 (1–3), 216–223.
   PubMed Web of Science ®Google Scholar
• Shen, Y., Aoyagi-Scharber, M., and Wang, B., 2015. Trapping Poly(ADP-Ribose) polymerase. The Journal of Pharmacology and Experimental Therapeutics, 353 (3), 446–457.
   PubMed Web of Science ®Google Scholar
• Škėmienė, K., et al., 2013. Protecting the heart against ischemia/reperfusion-induced necrosis and apoptosis: the effect of anthocyanins. Medicina, 49 (2), 15.
   PubMed Web of Science ®Google Scholar
• Sohanaki, H., et al., 2016. Pelargonidin improves memory deficit in amyloid β25-35 rat model of Alzheimer's disease by inhibition of glial activation, cholinesterase, and oxidative stress. Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie, 83, 85–91. ‏
   PubMed Web of Science ®Google Scholar
• Sreemantula, S., et al., 2005. Indirect biochemical evidence that reserpine methiodide produces selective depletion of peripheral biogenic amines in rats. Die Pharmazie, 60 (4), 294–297.
   PubMed Web of Science ®Google Scholar
• Su, H., et al., 2020. Pelargonidin-3-O-glucoside derived from wild raspberry exerts antihyperglycemic effect by inducing autophagy and modulating gut microbiota. Journal of Agricultural and Food Chemistry, 68 (46), 13025–13037.
   PubMed Web of Science ®Google Scholar
• Turpeenoja, L., et al., 1988. Changes of mitochondrial membrane proteins in rat cerebellum during aging. Neurochemical Research, 13 (9), 859–865.
   PubMed Web of Science ®Google Scholar
• Virág, L., and Szabó, C., 2002. The therapeutic potential of poly (ADP-ribose) polymerase inhibitors. Pharmacological Reviews, 54 (3), 375–429.
   PubMed Web of Science ®Google Scholar
• Wang, Y., et al., 2019. Mitochondrial dysfunction in neurodegenerative diseases and the potential countermeasure. CNS Neuroscience & Therapeutics, 25 (7), 816–824.
   PubMed Web of Science ®Google Scholar
• Whitfield, C.D., et al., 1981. Hamster cell mutants unable to grow on galactose and exhibiting an overlapping complementation pattern are defective in the electron transport chain. The Journal of Biological Chemistry, 256 (13), 6651–6656.
   PubMed Web of Science ®Google Scholar
• Zhang, X., et al., 2020. CD38 causes autophagic flux inhibition and cardiac dysfunction through a transcriptional inhibition pathway under hypoxia/ischemia conditions. Frontiers in Cell and Developmental Biology, 8, 191.
   PubMed Web of Science ®Google Scholar